Low dose nicotine attenuates Aβ neurotoxicity through activation early growth response gene 1 pathway

PLoS One. 2015 Mar 27;10(3):e0120267. doi: 10.1371/journal.pone.0120267. eCollection 2015.

Abstract

Epidemiological studies indicate that smoking is negatively correlated with the incidence and development of Alzheimer's disease (AD). Nicotine was reported to be the active factor. However, the detailed mechanisms still remain to be fully elucidated. Early growth response gene 1 (EGR-1) plays important roles in several important biological processes such as promoting cell growth, differentiation, anti oxidative stress, and apoptosis, but few in the pathogenesis of AD. In the present study, we show that nicotine can activate the MAPK/ERK/EGR-1 signaling pathway partially through α7 nAChR. In addition, the up-regulation of EGR-1 by nicotine can also increase the phosphorylation of CyclinD1 which contributes to the attenuation of amyloid-β (Aβ(25-35)) -induced neurotoxicity. Although nicotine and Aβ(25-35) can activate EGR-1, the expression of EGR-1 is down-regulated following treatment with nicotine and Aβ(25-35). This study demonstrates that low dose nicotine attenuates Aβ(25-35)-induced neurotoxicity in vitro and in vivo through activating EGR-1 pathway.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alzheimer Disease / metabolism
  • Alzheimer Disease / prevention & control*
  • Amyloid beta-Peptides / metabolism*
  • Animals
  • Apoptosis / drug effects
  • Blotting, Western
  • Cell Proliferation / drug effects
  • Cells, Cultured
  • Dose-Response Relationship, Drug
  • Early Growth Response Protein 1 / genetics
  • Early Growth Response Protein 1 / metabolism*
  • Fluorescent Antibody Technique
  • Gene Expression Regulation / drug effects*
  • Hippocampus / cytology
  • Hippocampus / drug effects*
  • Hippocampus / metabolism
  • Humans
  • Immunoenzyme Techniques
  • Male
  • Mice, Inbred C57BL
  • Neuroblastoma / metabolism
  • Neuroblastoma / pathology
  • Neuroblastoma / prevention & control*
  • Neurons / cytology
  • Neurons / drug effects
  • Neurons / metabolism
  • Nicotine / pharmacology*
  • PC12 Cells
  • RNA, Messenger / genetics
  • Rats
  • Real-Time Polymerase Chain Reaction
  • Reverse Transcriptase Polymerase Chain Reaction
  • Signal Transduction / drug effects

Substances

  • Amyloid beta-Peptides
  • EGR1 protein, human
  • Early Growth Response Protein 1
  • RNA, Messenger
  • Nicotine

Grants and funding

This work was supported by National Science Foundation in China (2014J01375; 81271421). The Natural Science Foundation of Fujian Province of China (Grant: 2013J01147; and 2014J06019). This work was also supported by Program for New Century Excellent Talents in University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.